Catalyst Wire Dossier Catalyst Wire Dossier

Equine F(ab')2 antivenom

equine F(ab')2 antivenom · Instituto Bioclon S.A. de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Equine F(ab')2 antivenom, covering 2018-12-13 to 2018-12-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in Morocco [Phase 2, Phase 3]

See pricing